| Title : Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78\/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis - Mavropoulos_2005_J.Rheumatol_32_2116 |
| Author(s) : Mavropoulos JC , Cuchacovich M , Llanos C , Aguillon JC , Gatica H , Pizzo SV , Gonzalez-Gronow M |
| Ref : J Rheumatol , 32 :2116 , 2005 |
| Abstract : Mavropoulos_2005_J.Rheumatol_32_2116 |
| ESTHER : Mavropoulos_2005_J.Rheumatol_32_2116 |
| PubMedSearch : Mavropoulos_2005_J.Rheumatol_32_2116 |
| PubMedID: 16265688 |
Mavropoulos JC, Cuchacovich M, Llanos C, Aguillon JC, Gatica H, Pizzo SV, Gonzalez-Gronow M (2005)
Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78\/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis
J Rheumatol
32 :2116
Mavropoulos JC, Cuchacovich M, Llanos C, Aguillon JC, Gatica H, Pizzo SV, Gonzalez-Gronow M (2005)
J Rheumatol
32 :2116